Advertisement
Screener

PUMA BIOTECHNOLOGY, INC. (PBYI) Variable Lease, Cost

2.8 / 5 stars · 68/120 Roast Me

PUMA BIOTECHNOLOGY, INC. Variable Lease, Cost

PUMA BIOTECHNOLOGY, INC. (PBYI) reported Variable Lease, Cost of $300.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.

Discontinued › Expense Statement › Operating Expenses

us-gaap:VariableLeaseCost · last filed 2021-11-04

  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for the quarter ending 2021-09-30 was $100.00K, a 0.00% change year-over-year.
  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for the quarter ending 2021-06-30 was $100.00K, a 0.00% change year-over-year.
  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for the quarter ending 2021-03-31 was $100.00K, a 0.00% change year-over-year.
  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for the quarter ending 2020-12-31 was $100.00K, a 0.00% change year-over-year.
  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for fiscal 2020 was $400.00K, a 0.00% change from fiscal 2019.
  • PUMA BIOTECHNOLOGY, INC. variable lease, cost for fiscal 2019 was $400.00K.
Period endVariable Lease, Cost 3 monthVariable Lease, Cost 6 monthVariable Lease, Cost 9 monthVariable Lease, Cost 12 month
2021-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$200.00K
derived: sum of 2 quarters · filed 2021-11-04
$300.00K
10-Q · filed 2021-11-04
$400.00K
derived: sum of 4 quarters · filed 2021-11-04
2021-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$200.00K
10-Q · filed 2021-08-05
$300.00K
derived: sum of 3 quarters · filed 2021-08-05
$400.00K
derived: sum of 4 quarters · filed 2021-11-04
2021-03-31$100.00K
10-Q · filed 2021-05-06
$200.00K
derived: sum of 2 quarters · filed 2021-05-06
$300.00K
derived: sum of 3 quarters · filed 2021-11-04
$400.00K
derived: sum of 4 quarters · filed 2021-11-04
2020-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$200.00K
derived: sum of 2 quarters · filed 2021-11-04
$300.00K
derived: sum of 3 quarters · filed 2021-11-04
$400.00K
10-K · filed 2021-03-01
2020-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$200.00K
derived: sum of 2 quarters · filed 2021-11-04
$300.00K
10-Q · filed 2021-11-04
$400.00K
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$200.00K
10-Q · filed 2021-08-05
$300.00K
derived: sum of 3 quarters · filed 2021-08-05
$400.00K
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$100.00K
10-Q · filed 2021-05-06
$200.00K
derived: sum of 2 quarters · filed 2021-05-06
$300.00K
derived: sum of 3 quarters · filed 2021-05-06
$400.00K
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$200.00K
derived: sum of 2 quarters · filed 2020-11-05
$300.00K
derived: sum of 3 quarters · filed 2020-11-05
$400.00K
10-K · filed 2020-02-28
2019-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$200.00K
derived: sum of 2 quarters · filed 2020-11-05
$300.00K
10-Q · filed 2020-11-05
2019-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$200.00K
10-Q · filed 2020-08-06
2019-03-31$100.00K
10-Q · filed 2020-05-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARVINAS, INC. (ARVN)United States$0.510B58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Evolus, Inc. (EOLS)United States$0.519B-13.32
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76